CVS Health strikes deal for Omincare

• CVS Health (NYSE:CVS) confirms it will acquire Omnicare (NYSE:OCR) for $98 per share in a deal valued at $12.7B.
• The transaction is expected to close near the end of the year.
• The company sees the purchase adding $0.20 to EPS in 2016
• Previously: Bloomberg: CVS in advanced talks to buy Omnicare
• OCR +1.39% premarket to $95.95.
• CVS +1.77% premarket to $103.06.